Mesothelioma Clinical Trials Overview > Mesothelioma Clinical Trial List
Pemetrexed Disodium and Cisplatin Followed By Surgery and Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma
| Conditions: | Malignant Mesothelioma |
| Start Date: | July 1, 2005 |
| Phase: | Phase II |
| Status: | Active, not recruiting |
| NCT ID: | NCT00227630 |
| Study Type: | Interventional |
| Intervention: | Drug: cisplatin|Drug: pemetrexed disodium|Procedure: adjuvant therapy|Procedure: conventional surgery|Procedure: neoadjuvant therapy|Radiation: radiation therapy |
| Study Design: | Allocation: Non-Randomized|Primary Purpose: Treatment |
| Results: | No Results Available |
| Sponsors: | European Organization for Research and Treatment of Cancer |
| Ages: | Child|Adult|Senior |
| Enrollment: | 52 |
| Funded By: | Other |
| First Received: | September 26, 2005 |
| End Date: | |
| Last Updated: | June 10, 2010 |
| Last Verified: | November 1, 2006 |
Mesothelioma
Lawsuit Evaluation
Lawsuit Evaluation
